Trends in Healthcare Utilization and Treatments of Infantile Hemangioma in the United States: Analysis of the National Ambulatory Medical Care Survey (<scp>NAMCS</scp>) 2009–2019
The US healthcare utilization for IH has been on the rise between 2009 and 2019, likely owing to increased awareness, earlier diagnosis, and enhanced therapies. While topical beta-blocker prescriptions have significantly increased during that period of time, systemic beta-blocker prescription rates have not.
Authors
- Megha M. Tollefson (ORCID: https://orcid.org/0000-0002-4023-9433)
- Mohsen Afarideh (ORCID: https://orcid.org/0000-0002-3578-5640)
- Katelyn Anderson (ORCID: https://orcid.org/0000-0001-7129-4032)
Institutions
- Mayo Clinic (US)
- WinnMed (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- Pediatric Dermatology
- Published
- 2025-08-28
- DOI
- https://doi.org/10.1111/pde.16040
- Primary Topic
- Vascular Malformations and Hemangiomas
- Type
- article
- Field-Weighted Citation Impact
- 0.00